The Hevesy Laboratory, DTU Nutech, Technical University of Denmark , Roskilde, Denmark.
Biomacromolecules. 2014 May 12;15(5):1625-33. doi: 10.1021/bm401871w. Epub 2014 Apr 7.
Copolymers of ABC-type (PEG-PHEMA-PCMA) architecture were prepared by atom transfer radical polymerization and formulated as micelles with functionalizable primary alcohols in the shell-region (PHEMA-block) to which the metal-ion chelators DOTA or CB-TE2A were conjugated. Using this micelle system we compared the in vivo stabilities of DOTA and CB-TE2A as chelators of (64)Cu in micelle nanoparticles. The coumarin polymer (PCMA-block) micelle core was cross-linked by UV irradiation at 2 W/cm(2) for 30 min. The cross-linked micelles were labeled with (64)Cu at room temperature for 2 h (DOTA) or 80 °C for 3 h (CB-TE2A), giving labeling efficiencies of 60-76% (DOTA) and 40-47% (CB-TE2A). (64)Cu-micelles were injected into tumor-bearing mice (8 mg/kg) and PET/CT scans were carried out at 1, 22, and 46 h postinjection. The micelles showed good blood stability (T1/2: 20-26 h) and tumor uptake that was comparable with other nanoparticle systems. The DOTA micelles showed a biodistribution similar to the CB-TE2A micelles and the tumor uptake was comparable for both micelle types at 1 h (1.9% ID/g) and 22 h (3.9% ID/g) but diverged at 46 h with 3.6% ID/g (DOTA) and 4.9% ID/g (CB-TE2A). On the basis of our data, we conclude that cross-linked PEG-PHEMA-PCMA micelles have long circulating properties resulting in tumor accumulation and that DOTA and CB-TE2A (64)Cu-chelates show similar in vivo stability for the studied micelle system.
ABC 型共聚物(PEG-PHEMA-PCMA)通过原子转移自由基聚合制备,并将具有可功能化伯醇的胶束制剂作为壳区(PHEMA 嵌段),其中金属离子螯合剂 DOTA 或 CB-TE2A 被共轭。使用这种胶束系统,我们比较了 DOTA 和 CB-TE2A 作为(64)Cu 在胶束纳米粒子中的螯合剂的体内稳定性。香豆素聚合物(PCMA 嵌段)胶束核在 2 W/cm(2)下用 UV 辐射交联 30 分钟。交联胶束在室温下用(64)Cu 标记 2 小时(DOTA)或 80°C 标记 3 小时(CB-TE2A),标记效率为 60-76%(DOTA)和 40-47%(CB-TE2A)。(64)Cu-胶束注入荷瘤小鼠(8mg/kg),在注射后 1、22 和 46 小时进行 PET/CT 扫描。胶束显示出良好的血液稳定性(T1/2:20-26 小时)和肿瘤摄取,与其他纳米粒子系统相当。DOTA 胶束的分布与 CB-TE2A 胶束相似,两种胶束类型在 1 小时(1.9%ID/g)和 22 小时(3.9%ID/g)时的肿瘤摄取量相当,但在 46 小时时差异较大,分别为 3.6%ID/g(DOTA)和 4.9%ID/g(CB-TE2A)。基于我们的数据,我们得出结论,交联 PEG-PHEMA-PCMA 胶束具有长循环特性,导致肿瘤积聚,并且 DOTA 和 CB-TE2A(64)Cu 螯合物在研究的胶束系统中显示出相似的体内稳定性。